Giant Cell Tumor of the Extrahepatic Biliary Tree: A Clinicopathologic Study of 4 Cases and Comparison With Anaplastic Spindle and Giant Cell Carcinoma With Osteoclast-Like Giant Cells

We report four previously undescribed primary giant cell tumors of the extrahepatic biliary tree and morphologically compare them with 10 anaplastic spindle and giant cell carcinomas with osteoclast-like giant cells of the gallbladder. Two giant cell tumors were located in the distal common bile duct; one in the cystic duct and one in the gallbladder. The 3 patients with bile duct tumors were male, and the only patient with a gallbladder tumor was a female. The age of the patients ranged from 45 to 60 years with an average of 55 years. The patients with bile duct tumors presented with biliary obstruction, and the patient with a gallbladder tumor presented with symptoms of cholelithiasis and a gallbladder mass. Histologically, the tumors were similar to giant cell tumors of bone. They consisted of a mixture of mononuclear and multinucleated osteoclast-like giant cells. The mononuclear cells showed no atypical features, and their nuclei were similar to those of the multinucleated giant cells. CD163 immunoreactivity was restricted to the mononuclear cells, whereas CD68 and HAM 56 labeled only the multinucleated osteoclast-like giant cells. The mononuclear cells were EMA-positive but did not express cytokeratins. Follow-up showed that 3 patients were alive and disease-free 3.7 to 7 years after surgery. The anaplastic spindle and giant cell carcinomas contained a fewer number of osteoclast-like giant cells, and their mononuclear cells showed considerable variation in size and shape, marked cytologic atypia, and numerous mitotic figures. They were focally cytokeratin positive (AE1/AE3; CAM 5.2) and did not label with CD163, CD68, and HAM 56. The benign osteoclast-like giant cells showed immunoreactivity for CD68 and HAM 56 but were negative for CD163 and cytokeratins. Giant cell tumors of the extrahepatic biliary tree are benign true histiocytic neoplasms that should be distinguished from the highly lethal anaplastic spindle and giant cell carcinomas with osteoclast-like giant cells by detailed cytologic analysis and immunohistochemical stains for CD163, CD68, HAM 56, and cytokeratins.

[1]  P. Chu,et al.  CD163: a specific marker of macrophages in paraffin-embedded tissue samples. , 2004, American journal of clinical pathology.

[2]  M. Hoang,et al.  Giant cell tumor of the skin: a morphologic and immunohistochemical study of five cases. , 2002, Annals of diagnostic pathology.

[3]  K. Fu,et al.  Primary mediastinal giant cell tumors: a clinicopathologic and immunohistochemical study of two cases. , 2002, Annals of diagnostic pathology.

[4]  L. Thompson,et al.  Giant Cell Tumor of the Larynx: A Clinicopathologic Series of Eight Cases and a Review of the Literature , 2001, Modern Pathology.

[5]  D. Schaer,et al.  Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteine-rich family , 2001, Immunogenetics.

[6]  D. Heilman,et al.  Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry. , 2000, American journal of clinical pathology.

[7]  V. Adsay,et al.  "Histiocytic markers" in melanoma. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[8]  R. Beelen,et al.  Regulation of CD163 on human macrophages: cross‐linking of CD163 induces signaling and activation , 1999, Journal of leukocyte biology.

[9]  A. Folpe,et al.  Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  P. Gumerlock,et al.  Undifferentiated carcinoma with osteoclast‐like giant cells of the pancreas and periampullary region , 1998, Cancer.

[11]  A. Cheung,et al.  Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas? , 1997, Human pathology.

[12]  D. Henson,et al.  Unusual malignant epithelial tumors of the gallbladder. , 1996, Seminars in diagnostic pathology.

[13]  M. Younes,et al.  HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  D. Mason,et al.  A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily , 1993, European journal of immunology.

[15]  W. Tsang,et al.  KP1 (CD68) staining of granular cell neoplasms: is KP1 a marker for lysosomes rather than the histiocytic lineage? , 1992, Histopathology.

[16]  E. Kaiserling,et al.  Acute myeloid leukemia: immunohistologic findings in paraffin-embedded bone marrow biopsy specimens. , 1990, Human pathology.

[17]  P. Maheswaran,et al.  Osteoclastoma‐like giant cell tumour of the skin , 1990, Histopathology.

[18]  H. Radzun,et al.  Ki-M8 monoclonal antibody reactive with an intracytoplasmic antigen of monocyte/macrophage lineage. , 1987, Blood.

[19]  R. Voegeli,et al.  A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. , 1987, Experimental cell biology.

[20]  L. Kindblom,et al.  Malignant giant cell tumor of soft tissues: A clinicopathologic, cytologic, ultrastructural, angiographic, and microangiographic study , 1981, Cancer.

[21]  F. Enzinger,et al.  Malignant giant cell tumor of soft parts. An analysis of 32 cases. , 1972, Cancer.